Endometrial bleeding
Author:
- The ESHRE Capri Workshop GroupTGThe ESHRE Capri Workshop Group
Open Access
- 2 March 2007
- journal article
- review article
- Published by Oxford University Press (OUP) in Human Reproduction Update
- Vol. 13 (5) , 421-431
Abstract
Abnormal bleeding is a significant health problem, especially during adolescence and before menopause when anovulatory cycles are common. Curettage is rarely necessary to investigate or treat menstrual problems in adolescents, and its use should also be minimized in women younger than 40 years. In every age group, medical treatment is the initial choice, but surgical treatment by endometrial destruction or hysterectomy is sometimes required. Benign causes of bleeding include fibroids and possibly adenomyosis, but the indications for treatment in each case depend upon the extent of bleeding, not the extent of the lesion. Breakthrough bleeding (BTB) with combined oral contraceptives commonly leads to discontinuation of the method. As BTB tends to improve with time, in the first 3 months of pill use, unless there are obvious underlying causes, women should be reassured that it will likely settle. BTB is often the reason for discontinuing progestogen-only contraception, and there is a need for effective means of treating unscheduled bleeding. Bleeding occurs in ∼3% of post-menopausal women, and the use of hormones increases the likelihood of bleeding by >5-fold. Knowledge of the underlying mechanisms of bleeding is essential to the development of effective treatment.Keywords
This publication has 84 references indexed in Scilit:
- Tamoxifen treatment of bleeding irregularities associated with Norplant useContraception, 2005
- The relationship between the endocrine characteristics and the regularity of menstrual cycles in the approach to menopauseMenopause, 2005
- Menopausal Symptoms and Treatment-Related Effects of Estrogen and Progestin in the Womenʼs Health InitiativeObstetrics & Gynecology, 2005
- Women's and providers' attitudes toward menstrual suppression with extended use of oral contraceptivesContraception, 2004
- Effects of Estrogen Plus Progestin on Gynecologic Cancers and Associated Diagnostic ProceduresThe Women's Health Initiative Randomized TrialJAMA, 2003
- Development of the Hypothalamic‐Pituitary‐Ovarian AxisAnnals of the New York Academy of Sciences, 1997
- Prostaglandins and menstruationEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 1996
- Comparative profiles of reliability, cycle control and side effects of two oral contraceptive formulations containing 150 μg desogestrel and either 30 μg or 20 μg ethinyl oestradiolBJOG: An International Journal of Obstetrics & Gynaecology, 1993
- Endocrine Determinants of Fertility: Serum Androgen Concentrations during Follow-up of Adolescents into the Third Decade of Life*The Journal of Clinical Endocrinology & Metabolism, 1990
- The Primate Ovary: Critique and Perspectives1987